Brief: Verrica Pharmaceuticals Announces Launch Of Ycanth® For The Treatment Of Molluscum Contagiosum In Japan
09/02/2026 14:59
Feb 9 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O: VERRICA PHARMACEUTICALS ANNOUNCES LAUNCH OF YCANTH® FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM IN JAPAN BY PARTNER TORII PHARMACEUTICAL Source text: ID:nGNXbN3McF Further company coverage: VRCA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data